A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2006
12/14/2006	US20060280758 Modified vaccinia ankara virus variant
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	US20060280729 Cellular therapy for ocular degeneration
12/14/2006	US20060280728 Trimeric OX40-immunoglobulin fusion protein and methods of use
12/14/2006	US20060280725 Compositions and methods of treating and diagnosing hepatoma
12/14/2006	DE10234905B4 Verfahren zur Verbesserung des akustisch induzierten Molekültransfers Method of improving the acoustic-induced molecule transfers
12/14/2006	CA2615638A1 Herpes virus-based compositions and methods of use
12/14/2006	CA2613889A1 A cellular therapy for ocular degeneration
12/13/2006	EP1731609A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
12/13/2006	EP1731605A1 Cancer antigen peptides derived from wt1
12/13/2006	EP1731602A1 Pharmaceutical composition for lowering blood sugar level
12/13/2006	EP1731599A1 Method of constructing recombinant herpes simplex virus
12/13/2006	EP1731531A2 Multiple cytokine-antibody complexes
12/13/2006	EP1731171A1 Preventive/remedy for respiratory diseases
12/13/2006	EP1731166A2 Streptococcus pneumoniae proteins and vaccines
12/13/2006	EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/13/2006	EP1731144A1 Identification of genes altered in multiple myeloma
12/13/2006	EP1730537A2 Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1)
12/13/2006	EP1730520A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
12/13/2006	EP1730309A2 Compositions and methods for optimizing cleavage of rna by rnase h
12/13/2006	EP1730290A2 Compositions and methods for biodegradable polymer-peptide mediated transfection
12/13/2006	EP1730286A2 Therapeutic anti-cancer dna
12/13/2006	EP1730282A1 Glycosylation variants of ricin-like proteins
12/13/2006	EP1730280A2 Rna interference modulators of hedgehog signaling and uses thereof
12/13/2006	EP1730263A2 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
12/13/2006	EP1729849A2 Implantable system for controlling gene expression
12/13/2006	EP1729817A1 Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin
12/13/2006	EP1729816A2 Transcription factor rna interference reagents and methods of use thereof
12/13/2006	EP1729802A2 Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
12/13/2006	EP1729798A1 Antigen specific t cell therapy
12/13/2006	EP1729780A2 Methods for protein production
12/13/2006	EP1615670A4 Targets for tumor growth inhibition
12/13/2006	EP1440079B1 Acyclic linker-containing oligonucleotides and uses thereof
12/13/2006	EP1343896B1 Small acid-soluble spore protein and uses thereof
12/13/2006	EP1287133B1 Regulation of human dopamine-like g protein-coupled receptor
12/13/2006	EP1179067B1 Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily
12/13/2006	EP1147208B1 Compositions and methods for intraductal gene therapy
12/13/2006	EP1123392B1 Prv-1 gene and the use thereof
12/13/2006	EP1121441B1 Selectively replicating viral vectors
12/13/2006	EP1097193B1 Liver stem cell
12/13/2006	EP1024836B1 Compositions for delivering genes to antigen presenting cells of the skin
12/13/2006	EP1021550B1 Use of beta recombinase in eukaryotic cells, especially for transgenic work
12/13/2006	EP0973914B1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
12/13/2006	EP0968284B1 An improved method for the production and purification of adenoviral vectors
12/13/2006	EP0927043B1 Compositions for gene transfer to the central nervous system
12/13/2006	EP0883343B1 Compositions for treating ischemic tissue
12/13/2006	EP0809695B1 Transcription factor - e2f-5
12/13/2006	EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006	CN1878867A Recombinant peptide vector comprising the gene for treatment for autoimmune diseases
12/13/2006	CN1878566A Multi-antigen vectors of melanoma
12/13/2006	CN1876820A Purification method adapted to mass production of plasmid DNA
12/13/2006	CN1876818A Recombinant plasmid capable of efficiently expressing human liver growth factor in eukaryotic cell
12/13/2006	CN1876815A Preparation method for siRNA molecule with single chain polyA tail and application thereof
12/13/2006	CN1876814A Design and preparation of certain-length single chain polyA RNA molecule and application thereof
12/13/2006	CN1876681A Cancer-suppressing protein and its gene and uses
12/13/2006	CN1289681C Construction of hepatitis B virus siRNA expression vector and its application in antivirus treatment
12/13/2006	CN1289674C DNA vaccine-PCV
12/13/2006	CN1289526C Stem cell factor
12/13/2006	CN1289148C Carrier suitable for gene delivery and its preparation process
12/13/2006	CN1289146C Nucleic acid vaccine for preventing and treating hepatitis B virus inflammation and its preparation
12/12/2006	US7148341 Adenovirus associated nucleotide sequences; for use as gene transfer tool in genetic engineerinf in the
12/12/2006	US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006	US7148205 Intravascular delivery of non-viral nucleic acid
12/12/2006	US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation
12/12/2006	US7148035 Polypeptide
12/12/2006	US7148015 Circovirus sequences associated with piglet weight loss disease (PWD)
12/12/2006	US7148014 Methods of inhibiting phagocytosis
12/12/2006	US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
12/12/2006	US7147848 Administering hybrid polio viruse to tumor, cancer
12/12/2006	US7147846 Preparing cell and protein bound grafts for use in the treatment of heart defects; tissue engineering and repai; artificial heart grafts and blood flowing tissues
12/12/2006	CA2153336C Recombinant virus immunotherapy
12/07/2006	WO2006130672A1 Glucose inducible insulin expression and methods of treating diabetes
12/07/2006	WO2006130560A2 Manipulation of pten in t cells as a strategy to modulate immune responses
12/07/2006	WO2006130201A1 Antigene oligomers inhibit transcription
12/07/2006	WO2006130076A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129594A1 Method for producing nucleic acid-containing complex preparation
12/07/2006	WO2006129393A1 Composition for treating periodontal disease
12/07/2006	WO2006129080A1 Materials and methods for transducing cells with a viral vector
12/07/2006	WO2006128245A1 Targeting cells with altered microrna expression
12/07/2006	WO2006099021A9 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling
12/07/2006	WO2005089252B1 Methods and compositions for the treatment of obesity
12/07/2006	WO2005079848A9 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
12/07/2006	WO2005046570A3 Human stem cell materials and methods
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060277613 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera
12/07/2006	US20060276548 Inhibitors of endo-exonuclease activity for treating cancer
12/07/2006	US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006	US20060276426 Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor
12/07/2006	US20060276425 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
12/07/2006	US20060276424 Compositions and Methods for Treatment of Prostate and Other Cancers
12/07/2006	US20060276423 Survivin-directed RNA interference-compositions and methods
12/07/2006	US20060276422 Useful for modulating the expression of genes, such as those genes associated with tumor mediated immunosuppression, immunopathology and/or proliferative diseases (e.g., cancer, restenosis, and polycystic kidney disease)
12/07/2006	US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent
12/07/2006	US20060276420 Generating cells for cell replacement therapy
12/07/2006	US20060276394 Methods and compositions for treating neurological disorders
12/07/2006	US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides
12/07/2006	US20060276391 Use of compounds that interfere with the Hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization

1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 870